Influence of regional and socioeconomic factors on mortality due to Guillain-Barré Syndrome (GBS) in Brazil (2017-2024)
DOI:
https://doi.org/10.5281/zenodo.14590560Keywords:
Guillain-Barré Syndrome, Mortality, Neurology, EpidemiologyAbstract
Introduction: Guillain-Barré Syndrome (GBS) is a rare neurological disorder characterized by an autoimmune response that leads to inflammation of peripheral nerves and destruction of the myelin sheath, a structure essential for efficient nerve impulse conduction. Methodology: The study employed a descriptive approach to analyze the influence of regional and socioeconomic factors on mortality caused by Guillain-Barré Syndrome (GBS) in Brazil from 2017 to 2024. The research relied exclusively on secondary data obtained from widely recognized public databases, such as the Mortality Information System (SIM) and DATASUS, both maintained by the Brazilian Ministry of Health. Results: Between 2017 and 2024, 1,751 deaths due to Guillain-Barré Syndrome (GBS) were recorded. There was a predominance of males (62.3%), with the highest concentration of deaths in the Southeast region (46.03%). Furthermore, 53.45% of deaths occurred among white individuals, and the age group most affected was 60 to 79 years. Conclusion: Data analysis revealed that factors such as unequal access to healthcare services, the distribution of medical infrastructure, and social determinants directly influence mortality rates for this neurological condition. Men, older adults, and white individuals were the most affected, with the Southeast concentrating the largest number of deaths, reflecting both higher population density and reporting capacity, as well as possible gaps in healthcare in other regions such as the North and Northeast.
References
ALESSANDRO, L.; CASTIGLIONE, J. I.; BRAND, P.; BRUNO, V.; BARROSO, F. Treatment-related fluctuations in Guillain-Barré syndrome: clinical features and predictors of recurrence. Arq Neuro-Psiquiatr, [S.l.], v. 80, n. 5, p. 516–522, 2022. Disponível em: https://doi.org/10.1590/0004-282X-ANP-2021-0226. Acesso em: 31 dez. 2024.
DEREBASI, Oguzhan; ISIK, Murat; DEMIRAG, Oguzhan; DURU, Dilek Goksel; DAS, Anup. A coupled neural circuit design for Guillain-Barre Syndrome. arXiv preprint, 2022. Disponível em: https://arxiv.org/abs/2206.13056. Acesso em: 31 dez. 2024.
HUGHES, R. A. C.; CORNBLATH, D. R. Guillain-Barré syndrome. The Lancet, v. 366, n. 9497, p. 1653-1666, 2005. DOI: 10.1016/S0140-6736(05)67665-9.
INSTITUTO NACIONAL DE DESÓRDENES NEUROLÓGICOS E DERRAME. Síndrome de Guillain-Barré. NINDS Español. Disponível em: https://espanol.ninds.nih.gov/es/trastornos/sindrome-de-guillain-barre. Acesso em: 31 dez. 2024.
LOPES, D. S. G.; ARAÚJO, I. de O.; GALLINDO, R. M.; RIBEIRO, C. T.; GENÉSIO, P. A. dos S. Síndrome de Guillain-Barré secundária à infecção por citomegalovírus em paciente pediátrico transplantado renal. Braz J Transplant, [S.l.], v. 27, p. e4124, 2024. Disponível em: https://doi.org/10.53855/bjt.v27i1.609_PORT. Acesso em: 31 dez. 2024.
MALAGA, M.; RODRIGUEZ-CALIENES, A.; VELASQUEZ-RIMACHI, V.; ALVA-DIAZ, C. Diagnosis of Guillain-Barré syndrome and use of Brighton criteria in Peruvian hospitals. Arq Neuro-Psiquiatr, [S.l.], v. 80, n. 6, p. 601–606, jun. 2022. Disponível em: https://doi.org/10.1590/0004-282X-ANP-2021-0225. Acesso em: 31 dez. 2024.
MARTÍNEZ, J. A.; PÉREZ, L. M.; GONZÁLEZ, R. A. Síndrome de Guillain-Barré: viejos y nuevos conceptos. Revista Mexicana de Neurociencia, v. 19, n. 1, p. 9-15, 2018. Disponível em: https://www.scielo.org.mx/scielo.php?pid=S0186-48662018000100009&script=sci_arttext. Acesso em: 31 dez. 2024.
MENDONÇA FILHO, V. C. M.; OLIVEIRA, A. G. de; MAIA, I. de F. V. C.; FALCONE, A. C. M. de; BETINI, B. G.; REZENDE, L. B.; et al. COVID-19 in the nervous system: physiopathology and neurological manifestations. Arq Neuro-Psiquiatr, [S.l.], v. 81, n. 8, p. 756–763, ago. 2023. Disponível em: https://doi.org/10.1055/s-0043-1769123. Acesso em: 31 dez. 2024.
RODRÍGUEZ, L. M.; GARCÍA, J. D.; HERNÁNDEZ, P. M. Etiología viral en el síndrome de Guillain-Barré. Revista de Neuro-Psiquiatría, v. 85, n. 3, p. 584-590, 2022. Disponível em: https://www.scielo.org.pe/scielo.php?pid=S2308-05312022000300584&script=sci_arttext. Acesso em: 31 dez. 2024.
SEJVAR, J. J.; BESSER, R.; FEIKIN, D.; TSOI, A.; REYES, M.; LANE, K.; LYNCH, M. F.; LUBY, S.; DOWELL, S. F. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology, v. 36, n. 2, p. 123-133, 2011. DOI: 10.1159/000324710.
SILVA, J. R.; ALMEIDA, F. L.; MOURA, C. R. Mortalidade por síndrome de Guillain-Barré no Brasil: fatores regionais e socioeconômicos. Revista Brasileira de Neurologia, v. 48, n. 2, p. 155-167, 2023.
VAN DEN BERG, B.; WALGAARD, C.; DRENTHEN, J.; FOKKE, C.; JACOBS, B. C.; VAN DOORN, P. A. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology, v. 10, n. 8, p. 469-482, 2014. DOI: 10.1038/nrneurol.2014.121.
WHO. World Health Organization. Global Cancer Observatory: Cancer Today. Disponível em: https://gco.iarc.fr/today/home. Acesso em: 26 dez. 2024.
WHO. World Health Organization. Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer, 2022. DOI: https://doi.org/10.3389/fonc.2022.1178773.
YUKSEL, P.; KIZILAY, F.; KOC, G.; KOC, O. N. Guillain-Barré syndrome after SARS-CoV-2 vaccination: A case report. Journal of Clinical Neuroscience, v. 89, p. 233-235, 2021. DOI: 10.1016/j.jocn.2021.05.014.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Social Issues and Health Sciences (JSIHS)
This work is licensed under a Creative Commons Attribution 4.0 International License.